Encefalitis viral por COVID-19: reporte de caso

Wang, 2020, Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China, JAMA., 323, 1061, 10.1001/jama.2020.1585 Huang, 2020, Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China, Lancet., 395, 497, 10.1016/S0140-6736(20)30183-5 Chen, 2020, Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study, Lancet., 395, 507, 10.1016/S0140-6736(20)30211-7 Gupta, 2020, Extrapulmonary manifestations of COVID-19, Nat Med., 26, 1017, 10.1038/s41591-020-0968-3 Ellul, 2020, Neurological associations of COVID-19, Lancet Neurol., 19, 767, 10.1016/S1474-4422(20)30221-0 Guan, 2020, Clinical characteristics of coronavirus disease 2019 in China, N Engl J Med., 382, 1708, 10.1056/NEJMoa2002032 Lai, 2020, Extra-respiratory manifestations of COVID-19, Int J Antimicrob Agents., 56, 106024, 10.1016/j.ijantimicag.2020.106024 Gu, 2005, Multiple organ infection and the pathogenesis of SARS, J Exp Med., 202, 415, 10.1084/jem.20050828 Yu, 2020, Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China, Microbes Infect., 22, 74, 10.1016/j.micinf.2020.01.003 Lu, 2020, Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding, Lancet., 395, 565, 10.1016/S0140-6736(20)30251-8 Moriguchi, 2020, A first case of meningitis/encephalitis associated with SARS-Coronavirus-2, Int J Infect Dis., 94, 55, 10.1016/j.ijid.2020.03.062 Correia, 2020, Neurological manifestations of COVID-19 and other coronaviruses: A systematic review, Neurol Psychiatry Brain Res., 37, 27, 10.1016/j.npbr.2020.05.008 Neumann, 2020, Cerebrospinal fluid findings in COVID-19 patients with neurological symptoms, J Neurol Sci., 418, 117090, 10.1016/j.jns.2020.117090 Barreto-Acevedo, 2020, Encefalitis aguda en pacientes COVID-19: primer reporte de casos en Perú, Rev Neuropsiquiatr., 83, 116, 10.20453/rnp.v83i2.3754 Gamal El-Din A. AR, Mamdouh F.A. M, Tarek S. I, Mai E. S, Ebtihal S, Rehab M. AEB. Potential repurposed SARS-CoV-2 (COVID-19) infection drugs. RSC Adv. 2020;10:26895-916.